Untreated type 1 diabetes increases sepsis-induced mortality without inducing a prelethal cytokine response

Shock

Volumn 34, Issue 4, 2010, Pages 369-376

  Osuchowski, Marcin F ^a,b   Craciun, Florin L ^a   Schuller, Elizabeth ^a   Sima, Corneliu ^a   Gyurko, Robert ^a   Remick, Daniel G ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

CLP; comorbidity; cytokine receptors; Glucose; hyperglycemia; inflammation; stratification

Indexed keywords

CXCL3 CHEMOKINE; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIGATION; LYMPHOCYTOPENIA; MORTALITY; MOUSE; NEUTROPENIA; NONHUMAN; PUNCTURE; SEPSIS; SURVIVAL RATE;

ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HYPOGLYCEMIA; MICE; SEPSIS;

EID: 77957697171     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181dc40a8     Document Type: Article

References (35)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
2. Deshpande AD, Harris-Hayes M, Schootman M: Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254-1264, 2008.
3. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS: The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 34:2576-2582, 2006.
4. Remick DG: Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des 9:75-82, 2003.
5. Yoshioka M, Kayo T, Ikeda T, Koizumi A: A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46:887-894, 1997.
6. Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A, Van Dyke TE: Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol 177:7250-7256, 2006.
7. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM: Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214YF222, 2006.
8. Basu R, Oudit GY, Wang X, Zhang L, Ussher JR, Lopaschuk GD, Kassiri Z: Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol. 297(6):H2096YH2108, 2009.
9. Schmidt RE, Green KG, Snipes LL, Feng D: Neuritic dystrophy and neuron-opathy in Akita (Ins2[Akita]) diabetic mouse sympathetic ganglia. Exp Neurol 216:207-218, 2009.
10. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK: The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210-2218, 2005.
11. Geerlings SE: Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31(suppl 1): S54YS57, 2008.
12. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW: Infections in patients with diabetes mellitus. N Engl J Med 341:1906-1912, 1999.
13. Stoeckle M, Kaech C, Trampuz A, Zimmerli W: The role of diabetes mellitus in patients with bloodstream infections. Swiss Med Wkly 138:512-519, 2008.
14. Dandona P, Chaudhuri A, Mohanty P, Ghanim H: Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 10:511-517, 2007.
15. Dandona P, Chaudhuri A, Ghanim H, Mohanty P: Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin Thorac Cardiovasc Surg 18:293-301, 2006.
16. Jain SK, Kannan K, Lim G, Matthews-Greer J, McVie R, Bocchini JA Jr: Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26:2139-2143, 2003.
17. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334, 2001.
18. Esper AM, Moss M, Martin GS: The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 13:R18, 2009.
19. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulmé R, et al.: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108-121, 2002.
20. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24(suppl 1):52-57, 2005.
21. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shockVa review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
22. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG: Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol 179:623-630, 2007.
23. Knight PR, Sreekumar A, Siddiqui J, Laxman B, Copeland S, Chinnaiyan A, Remick DG: Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock 21:26-30, 2004.
24. Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI: Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 30:995-1001, 2000.
25. De Oliveira Martins J, Meyer-Pflug AR, Alba-Loureiro TC, Melbostad H, Costa da Cruz JW, Coimbra R, Curi R, Sannomiya P: Modulation of lipopolysaccharide-induced acute lung inflammation: role of insulin. Shock 25: 260-266, 2006.
26. Alba-Loureiro TC, Pithon-Curi TC, Curi R: Reduced cytokine production by glycogen-elicited peritoneal cells from diabetic rats. Shock 30:308-310, 2008.
27. Bouma G, Nikolic T, Coppens JM, Van Helden-Meeuwsen CG, Leenen PJ, Drexhage HA, Sozzani S, Versnel MA: NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur J Immunol 35:225-235, 2005.
28. Jacob A, Steinberg ML, Yang J, Dong W, Ji Y, Wang P: Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes. Int J Clin Exp Med 1:22-31, 2008.
29. Brooks HF, Osabutey CK, Moss RF, Andrews PL, Davies DC: Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction. Metab Brain Dis 22:353-373, 2007.
30. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
31. Pape HC, Van Griensven M, Rice J, Gänsslen A, Hildebrand F, Zech S, Winny M, Lichtinghagen R, Krettek C: Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers. J Trauma 50:989-1000, 2001.
32. Lebovitz HE: Diabetic ketoacidosis. Lancet 345:767-772, 1995.
33. Cheung NW, Li S, Ma G, Crampton R: The relationship between admission blood glucose levels and hospital mortality. Diabetologia 51:952-955, 2008.
34. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M: Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36:2249-2255, 2008.
35. Leonidou L, Michalaki M, Leonardou A, Polyzogopoulou E, Fouka K, Gerolymos M, Leonardos P, Psirogiannis A, Kyriazopoulou V, Gogos CA: Stress-induced hyperglycemia in patients with severe sepsis: a compromising factor for survival. Am J Med Sci 336:467-471, 2008.